Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Dirks, M. Fousse, U. Sester, M. Sester (Homburg (Saar), Germany). Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals. Eur Respir J 2014; 44: Suppl. 58, 3252

Member's Comments

No comment yet.

Related content which might interest you: Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 CD27 expression as a new tool to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Functional and memory status of M. tuberculosis specific T-cells in HIV-infected patients naïve to antiretroviral treatment Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 The diagnosis of latent tuberculosis infection in children with new immunologic tests Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Features detection of tuberculosis in HIV-patients in the region with a high prevalence of tuberculosis Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 The cases of active tuberculosis among persons with latent tuberculosis infection residing in the disease hot spots Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Clinical management of tuberculosis and HIV-1 co-infection Source: Eur Respir J 2010; 36: 1460-1481 Year: 2010 Cellular and humoral immune response in non HIV infected tuberculous patients in Upper Egypt Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Using results of new laboratory test for tuberculosis infection in children Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Evaluation of IFNgamma release assays for detection of cellular immunity towards M. tuberculosis and CMV in samples from deceased donors Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Intracellular ESAT-6 vs flow cytometric analysis of CD4+IFN-γ+ cells for the diagnosis of mycobacterium tuberculosis infection in immunosuppressed patients Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Risk of developing active TB in children with latent TB infection Source: International Congress 2015 – Screening strategies in TB Year: 2015 Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014